We're #hiring a Postdoc to join us at IARC - please share! 🙏

Are you experienced in qualitative research? Are you interested in examining health system responses to the COVID-19 pandemic in low- and middle-income countries? Apply now!

More info 🔗 iarc.who.int/cards_page/pos…

Over 40 years of research, I learned #30: if a colleague or collaborator upsets you, first give them the benefit of the doubt; often, it is a result of a mistake or misunderstanding. Second, speak to the person directly - face-to-face, on the phone, or by video. Avoid email!

Over 40 years of research, I learned #28: reading and reflection are vital in order to retain creativity in research. If neglected, it is all too easy to simply do the next thing.

Marvellous example of what can be achieved by international cooperation and the integration of molecular science with epidemiology. Congratulations to Paul Brennan IARC Wellcome Sanger Institute Cancer Research UK and all those collaborators willing to share samples. nature.com/articles/s4158…

Pricing and #equity in access are major challenges in bringing the benefits of #geneediting to as many patients as possible globally.

And thanks to the brilliant Cancer Grand Challenges team at CRUK for their total support since Mutographs started, as well as wonderful scientific journey with Wellcome Sanger Institute and UC San Diego colleagues (esp Sarah Moody), partners in the 11 countries, and all the great team IARC.

Over 40 years of research, I learned #29: always look at raw data generated by people you are supervising and ensure you understand in detail the value and limitations of the methods being used. Becoming detached from either will lead to errors.

Latest global #cancer estimates, an essential foundation for cancer control: only Indian Republican has the necessary expertise and long-standing collaboration with cancer registries @GICR
GLOBOCAN incidence and mortality worldwide for 36 cancers in 185 countries acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…

#WorldImmunizationWeek
To eliminate #cervicalcancer , the WHO Global strategy sets 3 targets:
90% of girls vaccinated with the HPV vaccine by age 15
70% of women screened with a high-quality test by ages 35 and 45
90% of women with cervical disease receiving treatment.
World Health Organization (WHO)

Informative NEJM Perspective on #geneediting for #sicklecelldisease pointing to promise but also risks of further #inequality if patients from #LMICs can't access (due to high cost, lack of infrastucture, etc) Julie Makani WHO African Region SickleInAfrica
nejm.org/doi/full/10.10…

Over 40 years of research, I learned #27: research is never done, so it's vitally important to plan for rest. Thanks to my PhD supervisor, Roy Saffhill, who advised me, 'When you simply haven't time for a holiday, you need to take a holiday.' Rest improves research.

Over 40 years of research, I learned #26: as well as professional audiences, it's important to be able to explain your research to non-specialists, including friends and family (40 years ago, on seeing my 1st paper, my dad said: I don't understand a word, but well done!).

Over 40 years of research, I learned #25: for biomedical scientists, contact with patients is important in order to witness the impact of disease. Perhaps visit wards with clinical coll.; volunteer in hospitals or hospices; participate in patient advocacy grps. Remain attached.

New study in Science Advances has found that having an overall obese body shape or a tall, centrally obese body shape increases the risk of #colorectalcancer by + than 10% science.org/doi/10.1126/sc…

Over 40 years of research, I learned #24: research funding is increasingly concentrated in those institutes with a prior track record of obtaining funds. Early career scientists should look carefully at the institute and supervisor funding histories when deciding where to work.

Here we go, same old tactics and lobbying from big tobacco. The battle for this to go through to UK law is ongoing. Michelle Mitchell ASH #Stoptober Union for International #CancerControl
theguardian.com/society/2024/a…

Over 40 years of research, I learned #23: it is important to know when to end a line of research that is unlikely to bear fruit or to bear further significant fruit. It takes courage to stop something you have been invested in for a long time.

Over 40 years of research, I learned #22: if you are enthusiastic, spotting new research collaborations easily, there is a risk of becoming too dissipated, having too many projects at once. Knowing when to say no to a new opportunity is as important as knowing when to say yes.

Check out this job at World Health Organization: Director, Noncommunicable Diseases Without bias😉 The most exciting job in the Global Public Health world- please apply!!! linkedin.com/jobs/view/3881…

Over 40 years of research, I learned #21: #earlycareerscientists need opportunities to prepare and be named on grant applications. Sometimes, institute regulations can work against this goal. We need to be flexible, finding ways to meet this core training need.